Key Takeaways
- Volume-led quarter, margin squeeze: MCC volumes rose 16.5% YoY to 14,740 tons, but gross margin fell ~5% on raw material costs and low-margin API mix, while net profit jumped 108% YoY on a low base.
- Capacity expansion complete, ramp-up just starting: Total MCC capacity hit 21,000 MTPA after adding 7,200 tons; utilization sits at just 10% today, with management targeting 50% by Q4 FY25 and 80% by FY26.
- API entry is early and dilutive: The Trimax acquisition contributed ~INR45 crores in its first year at 15-16% gross margin; management targets 25% EBITDA margin only after regulatory filings unlock EU/US markets, which is an FY26 story.
- Middle East bets are large but unproven: Two subsidiary partnerships carry aspirational revenue potential of $54 mn by FY29 (MENA) and $180 mn in FY25 (Saudi Arabia), though neither has a demonstrated track record yet.
- What to watch next quarter: Whether MCC utilization climbs off the 10% floor as promised, whether API receivables collections normalize after the Q3-to-Q4 sales holdback, and whether the CCS environmental clearance finally arrives.
MCC: Volume Push, Pricing Sacrifice
- Volume growth came at a price: Management deliberately pushed quantities (14,740 tons sold) by compromising on realization to grab market share ahead of the capacity expansion coming online. Realization dropped to INR204-205 per kg from INR208 last year.
- Capacity utilization is the central bet: The newly added 7,200 MTPA across Dahej and Jhagadia is commissioned and validated, but running at only 10% utilization in the current month. Management describes the ramp as exponential, not linear, targeting 50% quarterly average by Q4 FY25 and 90% comfortably thereafter.
- Dahej disruption, Jhagadia compensation: Dahej facility output dipped slightly (4,616 to 4,487 tons) because expansion works caused production disturbances; Jhagadia increased far more than expected and made up the gap.
- Pricing recovery promised: Management expects MCC realization to rise at least 5% in FY25 as the need to buy market share recedes.
- Market share narrative: Management claims the market leader "has had a loss of direction" and that Sigachi is capturing share through capacity, quality, and regulatory approvals, though it declined to quantify current market share when asked.
Reddy: "Because keeping in view of our coming expansion capacities, we wanted to grab the market and in that process, we have pushed our products."
API (Trimax): Early Innings, Margin Drag
- Acquisition rationale and structure: Sigachi acquired 80% of Trimax Bio Sciences for INR100 crores, with a purchase call option on the remaining 20% after three years, adding APIs to its portfolio.
- Revenue contribution is material but low-quality: Trimax contributed around INR45 crores in its first year at gross margins of only 15-16%, with operating capacities still very low and the business still securing long-standing orders from quality customers.
- Q3-to-Q4 top-line drop was a collections issue: In Q3, good API sales went to select customers who then hit their credit limits and did not pay; management held back further sales and expects those to show up next quarter.
- Regulatory pathway is the margin unlock: Three CEP filings are already submitted, with four to five more slated for the current financial year. Management's primary focus is entering regulated markets, but FY25 will be mostly domestic sales with only a few regulatory-market entries; FY26 is when good margins are expected.
- FY25 margin expectations are modest: Operating margin for API in FY25 is pegged at 10-12%, with the 25% EBITDA margin target contingent on regulatory-market entry.
- Capacity expansion underway: INR60 crores earmarked to expand Trimax capacity by 150%, from 100 KL to 250 KL, with the balance 20% shareholders bringing in proportionate capex.
Sinha: "If the value of APIs are going to make up a significant portion of our sales, there is a going to be a slight hitch in terms of coming back to what we were two quarters back. But we are working to see how we can regularize this in the next three to four quarters."
O&M and CCS: Waiting on Clearance
- O&M segment has margin ambition: Management's stated objective is to qualify and penetrate businesses with better margin profiles, noting that winning low-margin business "is no big feat." Employee costs are higher for Middle East contracts but are partially offset by increased O&M revenue.
- CCS project stalled on environmental clearance: The Dahej CCS project has not received its EC because state-level authorities have not held meetings for three months due to impending elections. Management is waiting for the first week of June for committee meetings to resume.
- FY25 CCS revenue expectation: Around INR50-60 crores, contingent on the clearance coming through.
Sinha: "We have a situation where for the last three months, the authorities have not really sat on the table to have a meeting because of the impending elections. So everything is on a standstill in terms of decision making at the state level."
Middle East Subsidiaries: Large Aspirations
- Sigachi MENA (UAE): Wholly-owned subsidiary established a partnership with revenue potential of $54 million by FY29.
- Sigachi Arabia (Saudi Arabia): Subsidiary collaborated with Saudi National Projects Investment Limited, with anticipated revenue of approximately $180 million in FY25.
- No track record yet: Both partnerships are early-stage; no revenue contribution or operational milestones were disclosed for the quarter.
Financial Health: Capex, Returns, and Receivables
- ROCE is under pressure from the build-out: Return on capital employed is declining because of ongoing capacity expansion and increased capital work in progress of INR96.6 crores; management expects ROCE to improve as O&M projects ramp and new capacities come online.
- Gross margin regularization is a multi-quarter journey: Management is working to regularize gross margins in the next three to four quarters, though API revenue mix may cause a "slight hitch" in returning to prior levels.
- Receivables reduction plan: Management plans to reduce the collection period to 60-70 days within six to eight months.
- Goodwill revision: Goodwill increased from INR44 crores to INR55 crores due to implementation of Ind AS accounting standards.
- Warrant conversion: 30% of warrants have been converted; the remaining 70% will be fully converted in FY25.
Capex and Growth Framework
- FY25 capex plan: INR100 crores total, split across Trimax (INR30 crores), CCS (INR30 crores), and a new Hyderabad MCC facility (INR20 crores).
- FY26 capex plan: INR80-90 crores, covering the balance INR30 crores for the Raichur plant and around INR50 crores for CCS.
- Next MCC expansion trigger: Management will consider additional capex for further MCC growth only when utilization reaches 75-80% of the current 21,000-ton installed capacity.
- Growth ambition: The stated objective is to always grow at a CAGR higher than 33%, with growth described as "paramount" while protecting margins. The aspirational INR600-crore revenue target for FY25 remains intact.
Sinha: "Objective is to always be at a growth which is higher than 33% CAGR. Objective remains that and for that we keep working around to see which are complementary products in place, where there are opportunities in place, where there are growth markets coming in and expanding to geographies, markets, products accordingly."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| MCC capacity utilization | Reach 50% quarterly average | Q4 FY25 |
| MCC capacity utilization | Reach 80% | FY26 |
| MCC realization | At least 5% increase | FY25 |
| API operating margin | 10-12% | FY25 |
| API EBITDA margin | Approximately 25% | After regulatory-market entry (FY26+) |
| API revenue | INR100-120 crores | FY25 |
| CCS revenue | INR50-60 crores | FY25 (contingent on EC) |
| Receivables collection period | Reduce to 60-70 days | Within 6-8 months |
| Total capex | INR100 crores | FY25 |
| Total capex | INR80-90 crores | FY26 |
| Warrant conversion | Remaining 70% fully converted | FY25 |
| Revenue aspiration | INR600 crores | FY25 |
Key Metrics
| Metric | Q4 FY24 |
|---|---|
| Operating income | ₹104.1 cr, +43.78% YoY |
| EBITDA | ₹16.3 cr, +33.6% YoY; margin 15.65% |
| Net profit | ₹15.1 cr, +108.22% YoY; PAT margin 14.6% |
| FY24 total revenue | ₹398.9 cr, +32.08% YoY from ₹302 cr |
| FY24 EBITDA | ₹76.6 cr, +30.49% YoY; margin 19.2% |
| FY24 net profit | ₹57.2 cr, +31.19% YoY; PAT margin 14.34% |
| FY24 MCC revenue | ₹301.5 cr, +15.83% YoY |
| FY24 MCC volume | 14,740 metric tons, +16.47% YoY |
| FY24 O&M revenue | ₹35.1 cr, +32.45% YoY |
| FY24 API sales turnover | ~₹45 cr (first partial year of acquisition) |
| Total MCC capacity | 21,000 metric tons per annum, expanded by 7,200 MTPA at Dahej and Jhagadia |
| MCC capacity utilization target | 50% by Q4 FY25, rising to 80% by FY26 |
| API capacity utilization | 35%–40% currently; optimal 80%–85% |
| API revenue potential at full capacity | ₹200–250 cr annually from 250 KL at 100% utilization |
| FY25 capex | ~₹100 cr: Trimax ₹30 cr, CCS ₹30 cr, Hyderabad MCC ₹20 cr |
| FY25 aspirational revenue guidance | ₹600 cr |
| Sigachi Arabia anticipated revenue | ~$180 million in FY25 |
| Capital work in progress | ₹96.6 cr as of FY24 |
| Receivables | ₹150 cr as of March 2024 |